Membership of CPACT has given us invaluable access to a network of academic experts and companies from a variety of industries with whom share a common interest in developing and implementing process analytical and control technologies
Bob Samuel
About Us
One of the world's leading biotechnology companies,Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases.
Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 12,000 employees in locations spanning the globe and 2009 revenues of $4.5 billion.
With many established products and services helping patients in approximately 100 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences.
The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease, and diagnostic testing.
Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as cardiovascular disease, neurodegenerative diseases, and other areas of unmet medical need.
General Contact Information
| WWW: | http://www.genzyme.com/ |
|---|
CPACT Contact Information
Please note that this contact information is for CPACT related enquiries only.
Bob Samuel
| Address: | Genzyme 12 Rookwood Way Haverhill Suffolk CB9 8PB |
|---|---|
| Telephone: | 01440 707783 |
| Email: | bob.samuel@genzyme.com |